ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 582,54
-0,66%
Dow Jones
40 211,72
0,53%
DAX
18 504,69
-0,51%
Brent Oil
83,68
-0,78%
Bitcoin
62 674,42
-3,36%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
30/04/201523h58Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
29/04/201514h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce First Quarter 2015 Financial Results and Host Conference Call on Wednesday, May 6NASDAQ:PTLAPortola Pharmaceuticals Inc
14/04/201522h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
08/04/201514h00GlobeNewswire Inc.Portola Pharmaceuticals Announces New Topline Data From Phase 3 ANNEXA-A(TM) Trial Part 2: Breakthrough Designated Andexanet ...NASDAQ:PTLAPortola Pharmaceuticals Inc
29/03/201520h02The Motley Fool3 Up and Coming Biotech Stocks to WatchNASDAQ:PTLAPortola Pharmaceuticals Inc
11/03/201511h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTLAPortola Pharmaceuticals Inc
10/03/201514h29GlobeNewswire Inc.Portola Announces Pricing of Public Offering of Common StockNASDAQ:PTLAPortola Pharmaceuticals Inc
09/03/201521h12GlobeNewswire Inc.Portola Pharmaceuticals Announces Proposed Offering of Common StockNASDAQ:PTLAPortola Pharmaceuticals Inc
02/03/201523h14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTLAPortola Pharmaceuticals Inc
02/03/201514h01GlobeNewswire Inc.Portola Announces Full Results From Positive Phase 3 ANNEXA(TM)-R Study Demonstrating That Andexanet Alfa Rapidly and Signifi...NASDAQ:PTLAPortola Pharmaceuticals Inc
02/03/201514h00GlobeNewswire Inc.Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
26/02/201514h00GlobeNewswire Inc.Portola Pharmaceuticals Receives FDA Orphan Drug Designation for Andexanet Alfa, Its Breakthrough-Designated Factor Xa Inhibi...NASDAQ:PTLAPortola Pharmaceuticals Inc
25/02/201522h00GlobeNewswire Inc.Portola Pharmaceuticals to Present at the Cowen and Company 35th Annual Health Care ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
24/02/201522h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Fourth Quarter and Year End 2014 Financial Results and Host Conference Call on Monday, Ma...NASDAQ:PTLAPortola Pharmaceuticals Inc
24/02/201500h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
13/02/201519h46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
12/02/201516h54Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NASDAQ:PTLAPortola Pharmaceuticals Inc
11/02/201500h16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PTLAPortola Pharmaceuticals Inc
09/02/201522h00GlobeNewswire Inc.Portola Pharmaceuticals Appoints Two Biotechnology Industry Veterans, Laura Brege and Dr. Dennis Fenton, to Board of Director...NASDAQ:PTLAPortola Pharmaceuticals Inc
05/02/201522h06GlobeNewswire Inc.Portola's Factor Xa Inhibitor Betrixaban Successfully Passes Futility Analysis in Phase 3 APEX Study; Trial Continues as Plan...NASDAQ:PTLAPortola Pharmaceuticals Inc
26/01/201517h52GlobeNewswire Inc.Portola Pharmaceuticals Announces Dr. Robert Califf Retires From the Board of Directors to Accept Position as Deputy Commissi...NASDAQ:PTLAPortola Pharmaceuticals Inc
12/01/201514h00GlobeNewswire Inc.Portola Pharmaceuticals Initiates Phase 4 Study to Support Accelerated Approval of Andexanet Alfa -- Its Breakthrough-Designa...NASDAQ:PTLAPortola Pharmaceuticals Inc
09/01/201514h00GlobeNewswire Inc.Portola Announces Phase 3 ANNEXA-R Study of Andexanet Alfa and Factor Xa Inhibitor XARELTO(R) (rivaroxaban) Met Primary Endpo...NASDAQ:PTLAPortola Pharmaceuticals Inc
06/01/201522h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Webcast of Corporate Presentation on January 12, 2015NASDAQ:PTLAPortola Pharmaceuticals Inc
31/12/201415h52Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PTLAPortola Pharmaceuticals Inc
01/10/201422h09Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:PTLAPortola Pharmaceuticals Inc
06/08/201423h27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
30/07/201422h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Second Quarter 2014 Financial Results and Host Conference Call on Wednesday, August 6, 20...NASDAQ:PTLAPortola Pharmaceuticals Inc
10/07/201418h12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/07/201420h10GlobeNewswire Inc.Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement With Daiichi Sankyo for Phase 3 Studies of Factor Xa Inh...NASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

BIT
P24WN0
NLBNPIT24WN0 20991231 53...
LSE
0RAF
Amplitude Surgical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés